Evidence map›Paper›PMID 20702802›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2010

Heme oxygenase activity as a determinant of the renal hemodynamic response to low-dose ANG II.

Karl A Nath, Melissa C Hernandez, Anthony J Croatt, Zvonimir S Katusic, Luis A Juncos

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo.American journal of physiology. Heart and circulatory physiology · 2015
    Article
  5. Article
  6. Article
  7. Inhibition of heme oxygenase augments tubular sodium reabsorption.American journal of physiology. Renal physiology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karl A NathDivision of Nephrology and Hypertension, Mayo Clinic, Guggenheim 542, 200 First St., SW, Rochester, MN 55905, USA. nath.karl@mayo.edu
Melissa C Hernandez
Anthony J Croatt
Zvonimir S Katusic
Luis A Juncos
Hypertension Institute · USWinnMed · US

Funding

Renal Injury and Adaptation to Heme ProteinsR37DK047060 · NIDDK · MAYO CLINIC ROCHESTER · PI NATH, KARL A. · 2002 to 2011
$3.6M
RENAL INJURY AND ADAPTATION TO HEME PROTEINSR01DK047060 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NATH, KARL A. · 1993 to 2018
$2.2M
Supressor ANGII Determines Acute & Chronic Renal InjuryR01DK073401 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI JUNCOS, LUIS A. · 2006 to 2010
$1.6M
NIDDK NIH HHS DK-47060NIDDK NIH HHS DK-73401NIDDK NIH HHS R37 DK047060
6 · The paper itself

Abstract

ANG II causes renal injury through hemodynamic and other effects, and pressor doses of ANG II induce heme oxygenase-1 (HO-1) as a protective response. The present studies examined the hemodynamic effects of more clinically relevant, lower doses of ANG II and the role of HO activity in influencing these effects. Under euvolemic conditions, ANG II increased arterial pressure and renal vascular resistance. ANG II did not induce oxidative stress, inflammation/injury-related gene expression, or proteinuria and did not alter extrarenal vascular reactivity. At these doses, ANG II failed to increase HO-1 or HO-2 mRNA expression or HO activity. Inhibiting HO activity in ANG II-treated rats by tin mesoporphyrin further increased renal vascular resistances, decreased renal blood flow, and blunted the rise in arterial pressure without inducing oxidative stress or altering expression of selected vasoactive/injury/inflammation-related genes; tin mesoporphyrin did not alter vasorelaxation of mesenteric resistor vessels. We conclude that in this model renal vasoconstriction occurs without the recognized adverse effects of ANG II on glomerular filtration rate, renal blood flow, oxidative stress, vascular reactivity, proteinuria, and injury-related gene expression; renal HO activity is essential in preserving perfusion of the ANG II-exposed kidney. These findings represent an uncommon example wherein function of a stressed organ (by ANG II), but not that of the unstressed organ, requires intact renal HO activity, even when the imposed stress neither induces HO-1 nor HO activity. These findings may be germane to conditions attended by heightened ANG II levels, ineffective renal perfusion, and susceptibility to acute kidney injury.

Indexed as

Angiotensin IIAnimalsAortaBlood PressureDose-Response Relationship, DrugEnzyme InhibitorsGene Expression Regulation, EnzymologicHeme Oxygenase (Decyclizing)HemodynamicsInfusion Pumps, ImplantableInfusions, IntravenousKidneyMaleMesenteric ArteriesMetalloporphyrinsOxidative StressAngiotensin IIEnzyme Inhibitorsheme oxygenase-2Heme Oxygenase (Decyclizing)Hmox1 protein, ratMetalloporphyrinsRNA, Messengertin mesoporphyrinVasoconstrictor AgentsVasodilator Agents

Identifiers

PMID20702802
PMCPMC2980457
OpenAlexW2153653367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.